<DOC>
	<DOCNO>NCT00497406</DOCNO>
	<brief_summary>A study head neck cancer patient evaluate feasibility combine salivary gland transfer surgical procedure IMRT helical tomotherapy reduce dryness mouth .</brief_summary>
	<brief_title>A Pilot Study Evaluate Feasibility Combining Submandibular Salivary Gland Tx &amp; IMRT Tomo Reduce Xerostomia</brief_title>
	<detailed_description>Background Information Radiation therapy use definitive manner adjunct surgery head neck cancer patient inevitably lead xerostomia ( salivary gland dysfunction ) almost patient . Xerostomia debilitate condition adversely affect deglutition , mastication , gustation , speech lead increase susceptibility structure mouth infection . Xerostomia may also interfere nutrition sleep patient thereby significant negative impact patient 's quality life . Various modality explore prevent decrease incidence xerostomia successful method ; use Intensity modulate radiotherapy ( IMRT ) spare parotid salivary gland radiation , Sparing submandibular salivary gland radiation 's transfer sub mental space , use Amifostine protect salivary gland radiation use cholinergic agonist like pilocarpine stimulate salivary secretion . Both amifostine pilocarpine associate significant side effect amifostine costly use routine practice . At center , successful decrease incidence xerostomia significantly use either IMRT spar parotid gland ( Parliament et al 2004 ) submandibular gland transfer ( SGT ) spar submandibular gland ( Jha et al 2003 ) without compromise tumor control rate . Both modality associate added toxicity make method superior pilocarpine amifostine . To improve upon result spar major salivary gland , plan explore combined approach IMRT SGT head neck cancer patient surgery . For IMRT use `` step-and-shoot '' technique Varian 2300 EX linac 120-leaf Millenium MLC . Since December 2002 , Cross Cancer Institute helical tomotherapy unit disposal IMRT planning study ( van Vulpen et al 2005 ) conduct compare step-and-shoot IMRT Helical tomotherapy 5 oropharynx patient show tomotherapy plan compare favorably step- and-shoot plan regard spar parotid gland . Hence intend use helical tomotherapy IMRT tool study . Objectives - primary secondary Primary objective ass feasibility spar parotid transfer submandibular gland combine IMRT use helical tomotherapy SGT cancer oropharynx , larynx , hypopharynx primary surgery patient unknown primary cancer neck node neck dissection . Secondary objective assess incidence xerostomia subjectively xerostomia specific &amp; University Washington Quality Life Head Neck Symptom questionnaire objectively sialometry salivary scintigraphy parotid-sparing IMRT+ SGT . We also intend evaluate speech swallow function patient radiation . All functional outcome correlate dose-volume histogram salivary gland . Study Design Primary squamous cell carcinoma oropharynx , larynx , hypopharynx Unknown primary neck node squamous cell carcinoma histology ? Radical surgery primary cancer oropharynx , larynx , hypo pharynx Neck dissection unknown primary neck node + Selective neck dissection ( level I-III ) SGT opposite side lateralize primary side N0 neck midline primary IMRT Helical tomotherapy spar parotid gland transfer submandibular gland + chemotherapy Statistical Analysis - Power and/or Sample Size Relation This pilot study 12 patient consider feasible limit mean radiation dose one parotid one transfer submandibular gland less 26Gy give radiation dose 60Gy PTV 1 54 Gy PTV 2 .We intend report descriptive statistic related incidence severity xerostomia . Stopping Rules Radiation treatment withhold patient develops acute toxicity RTOG grade ? 4 unpredictable adverse event . Other , decision stop/delay treatment clinically indicate discretion treat physician . Data Safety Monitoring Committee Data handle Juliette Jordan per rule Alberta Cancer Board . Recruitment &amp; Eligibility Criteria `` Twelve patient histologically prove newly diagnose squamous cell carcinoma oropharynx , larynx , hypo pharynx unknown primary cancer neck node primary surgery recruit study. `` AJCC stage I-IV patient eligible provided M0 N0-2b. `` age 18 , Karnofsky performance status 70 `` patient must sign study-specific informed consent form `` Patients : N3/N2C/ M1 disease , salivary gland disease like Sjogren 's syndrome , prior concurrent malignancy , prior concurrent malignancy , pre-epiglottic space involvement pathological examination , involvement level I nod either side neck , post op recurrent disease presentation eligible study . Additional procedure investigation do study outline . Submandibular Gland Transfer We use retrograde flow method gland transfer . Retrograde flow flap well establish technique extensively use finger hand reconstruction . The gland dissect leave pedicled artery , vein , submandibular region . The great auricular nerve dissect , harvest preserve later use . The facial artery vein cut proximal branch supply gland . The efferent nerve submandibular ganglion also cut . The gland reposition submental space mylohyoid muscle cut allow reposition submandibular duct . The efferent nerve submandibular region reattached gland great auricular nerve interposition graft . In experience ( 200 patient far ) experience one case recurrence tumor graft area . Sialometry Whole salivary flow rate , unstimulated stimulate , measure floor mouth labial vestibule preoperatively 2-3 week surgery start radiation treatment . After radiation treatment , flow evaluation do 6 month 12 month . Each time , flow rate measure rest stimulation . Stimulated flow rate measure drop 0.2 ml 6 % citric acid solution dorsal surface tongue every 30 second ( Dawes 1975 ) .Salivary sample collect mean appliance ( Pederson et al 1985 ) consist Drummond micropipette holder ( use 20 microlitre micropipettes ) fit 2 ml latex dropper bulb . A 2.5 cm length 50 microlitre micropipette insert holder outer end long protrudes . During collection , patient tip head slight forward produce pool saliva anterior floor mouth mandibular labial vestibule . The micropipette extrude end collection device use aspirate pool salivary secretion two site . As saliva flow micropipette , spill glass sleeve collection device top silicon end-piece top micropipette . Salivary Scintigraphy Salivary gland scintigraphy carry use sodium pertechnate 99mTc 04 , surgery,2-3 week surgery 6 months,12 month radiation therapy evaluate morphology function `` transfer gland '' . This compare salivary gland morphology function receive radiation treatment . After 148 MBq 99mTc 04 rapidly injected computer acquisition 1 min frame , total 30 min . After 15 minute time point , patient request suck juice lemon straw , order provoke salivary secretion . Speech Swallowing Assessments This assessment do Head neck Surgery Functional Assessment Laboratory house within COMPRU Misericordia Hospital . Each patient schedule 4 predetermined assessment visits:1 ) preoperative ; 2 ) 2-4 week postoperative ; 3 ) 6-months post-radiation therapy ; 4 ) 1-year post radiation therapy . At session , speech , mastication , deglutition , quality life assess . Speech function assess record voice patient use audiotape . Masticatory efficiency assess use electrognathograph ( BioPak , Version 2.0 , Milwaukee , WI ) , clinical tool measure mandibular movement use sensory array track position magnet place patient 's mandibular incisor . After placement magnet mandibular dentition sensory array head , patient ask chew wine gum Â¼ digestive cookie . Various aspect mastication assess include number chew stroke time pass first swallow candy cookie . Swallowing function assess fluoroscopic visualization patient swallow food substance different consistency coat Barium .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>histologicallyproven newlydiagnosed squamous cell carcinoma oropharynx , larynx , hypopharynx unknown primary cancer neck node metastasis primary surgery AJCC stage IIV patient eligible provided MO NO2b 18 year age old KPS 70 great N3/N2C disease M1 disease salivary gland disease i.e . Sjogren 's syndrome prior concurrent malignancy except nonmelanomatous skin cancer unless diseasefree least 5 year prior radiotherapy head neck region lymph node involvement ( level IIII ) proximity disease submandibular gland side choose salivary gland transfer frozen section permanent pathological evaluation preepiglottic space involvement pathological examination involvement level I nod either side neck postop recurrent disease presentation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>submandibular salivary gland transfer</keyword>
	<keyword>intensity-modulated radiation therapy</keyword>
	<keyword>helical tomotherapy</keyword>
	<keyword>reduction xerostomia</keyword>
</DOC>